CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Pulse fibre +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01719900
NCT01719900N/ACompleted
CompareCT.gov

Evaluation of Pulse Fibre Supplementation in Obesity and the Metabolic Syndrome: Generating Evidence in Support of Health Claims

University of Calgary·interventional·Posted Nov 1, 2012·Updated Jan 21, 2020

In Brief

A clinical study evaluating Pulse fibre and Control for Obesity. Completed, enrolled 53 participants across 1 site.

Detailed Summary

The recent dramatic increase in obesity has been linked to a reduction of dietary fibre intake. We hypothesized that supplementing the diet of overweight and obesity adults with pulse fibre will improve their metabolic status, chiefly defined as greater weight loss. Other metabolic health improvements may include improved glucose control and reduced inflammatory markers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesCanada
CollaboratorsAlberta Innovates Health Solutions, Alberta Innovates Bio Solutions, Alberta Pulse Growers

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 1, 2012
Enrollment StartOct 1, 2012
Primary CompletionMay 1, 2013
Study CompletionNov 26, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 13.7 years ago

Interventions

Pulse fibredietary

Yellow pea hull fibre incorporated into a biscuit at 5 g/serving.

Controldietary

Control biscuit with no yellow pea hull fibre.